Home
About
Overview
Sharing Data
ORCID
Help
History (119)
Patient-Derived Tumor Xenografts: Why Now?
Remdesivir for the Treatment of Covid-19 - Final Report.
Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets.
Aortic Risk Redux.
Fighting Kinase Drug Resistance with Caspase Activators.
See All 119 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Fighting Kinase Drug Resistance with Caspase Activators.
Hardy JA. Fighting Kinase Drug Resistance with Caspase Activators. Cell Chem Biol. 2018 08 16; 25(8):927-928.
View in:
PubMed
subject areas
Apoptosis
Caspases
Cell Line, Tumor
Drug Resistance, Neoplasm
ErbB Receptors
authors with profiles
Jeanne A Hardy BS, PhD